New data from the Phase 1/2 clinical trial of CGT9486 in combination with sunitinib in patients with advanced GIST to be presented CAMBRIDGE, Mass., Oct. 5, 2020 /PRNewswire/ -- Unum Therapeutics Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results